Abbott Laboratories Sees $2.9M in Bullish Call Activity as Stock Hovers Near Mid-Range

By TrendSpider Editor

Abbott Laboratories is drawing significant attention in the options market Wednesday, with five unusual call contracts totaling $2,906,680 in premium flooding the tape as ABT shares trade at $103.15, down 0.56% on the session. All five contracts are out-of-the-money calls, signaling that options tra

Abbott Laboratories Sees $2.9M in Bullish Call Activity as Stock Hovers Near Mid-Range

Abbott Laboratories is drawing significant attention in the options market Wednesday, with five unusual call contracts totaling $2,906,680 in premium flooding the tape as ABT shares trade at $103.15, down 0.56% on the session. All five contracts are out-of-the-money calls, signaling that options traders are positioning for a meaningful move higher from current levels. With the stock sitting in the lower half of its 52-week range of $81.97 to $137.49, the positioning suggests some traders see a recovery runway ahead.

Key Drivers of the ABT Stock Move

• Main Catalyst: Five unusual call contracts printed across multiple strikes and expirations, generating $2,906,680 in total premium. The largest single print was a $1,160,000 block on the $110 strike calls expiring March 19, 2027, with volume hitting 282% of open interest, a signal of aggressive new positioning rather than a hedge against existing shares.
• Bull Case: The concentration of activity in calls at the $110 and $115 strikes, with expirations running out to March 2027, reflects conviction that ABT can reclaim those levels from its current price of $103.15. The $108 strike October calls printed at 812% of open interest on 268 contracts, indicating unusually high conviction relative to existing open interest in that contract.
• Bear Case: All five contracts are out-of-the-money, and ABT is still trading roughly 25% below its 52-week high of $137.49. The stock's mild 0.56% decline today suggests no immediate price momentum to support the bullish options thesis, and the broader trend from the annual high remains firmly downward.

The options positioning arrives at an interesting moment for Abbott. The spread of expirations across October 2026, December 2026, and March 2027 suggests traders are not betting on a single near-term catalyst but rather building a ladder of exposure that could benefit from a gradual recovery over the next six months. With ABT sitting closer to its 52-week low of $81.97 than its high of $137.49, the stock does carry meaningful technical upside if sentiment shifts. The size and breadth of today's unusual activity, spread across five distinct contracts at multiple strikes and dates, points to more than one participant building a bullish thesis independently, which can be a meaningful signal when aligned in direction.

ABT Unusual Options Activity

• Contract 1: Call, $110 strike, expiring October 16, 2026 | Volume: 773 | Open Interest: 18% | Out-of-the-money | Premium: $61,840
• Contract 2: Call, $110 strike, expiring March 19, 2027 | Volume: 2,000 | Open Interest: 282% | Out-of-the-money | Premium: $1,160,000
• Contract 3: Call, $110 strike, expiring March 19, 2027 | Volume: 1,500 | Open Interest: 211% | Out-of-the-money | Premium: $870,000
• Contract 4: Call, $115 strike, expiring December 18, 2026 | Volume: 3,900 | Open Interest: 86% | Out-of-the-money | Premium: $780,000
• Contract 5: Call, $108 strike, expiring October 16, 2026 | Volume: 268 | Open Interest: 812% | Out-of-the-money | Premium: $34,840

All five contracts were calls with no put activity detected. The $110 March 2027 strike attracted the most capital, accounting for over $2 million of the $2,906,680 in total premium across both prints at that strike and expiration. The $115 December 2026 contract saw the largest raw volume at 3,900 contracts for $780,000 in premium.

ABT Seasonality

Historically, the fourth quarter has been an active period for Abbott given its consistent earnings cadence and year-end medical device procurement cycles. Options traders positioning through December 2026 and into March 2027 may be timing exposure around upcoming quarterly reports and potential product cycle updates.

ABT Relative Performance

ABT is down 0.56% on the session at $103.15, underperforming on a modest basis. With a 52-week range of $81.97 to $137.49, the stock has retraced sharply from its annual peak, sitting roughly 25% below the high and only about 26% above its 52-week low, placing it in the lower half of its annual range and highlighting the gap that today's bullish options activity is implicitly targeting.